Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Varga

Showing results (281-290 of 389) with videos related to

Pageof 39
Sort By:
Developmental Science|August 23, 2023
Asynchronous development of memory integration and differentiation influences temporal memory organizationChristine Coughlin, Athula Pudhiyidath, Hannah E Roome, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2003
Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptorHippokratis Kiaris, Ioulia Chatzistamou, Andrew V Schally, et al.
Anti-Cancer Drugs|October 11, 2001
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormoneI Chatzistamou, A V Schally, J L Varga, et al.
Acta Medica Hungarica|January 1, 1983
Pentagastrin analogues containing alpha-aminooxy acids. VII. Catabolism in vivo and in vitro of a pentagastrin analogue containing N-terminal aminooxyacetyl residueL Varga, G Holzinger, J Németh, et al.
Scandinavian Journal of Gastroenterology|June 1, 1982
Sensitivity of the parietal cell to pentagastrin in health and duodenal ulcer disease: a reappraisalF Halter, U Bangerter, W H Häcki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2003
Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesinCelia A Kanashiro, Andrew V Schally, Kate Groot, et al.
Clinical and Experimental Immunology|April 23, 2010
Changes in the levels of some acute-phase proteins in human immunodeficiency virus-1 infected patients, following interleukin-2 treatmentV H Barbai, E Ujhelyi, J Szlávik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1aFelipe F Casanueva, Jesus P Camiña, Marcos C Carreira, et al.
Journal of Internal Medicine|November 20, 2020
A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiencyZs Pólai, Zs Balla, N Andrási, et al.
Injury|September 20, 2024
Controlled lumbar cerebrospinal fluid drainage effectively decreases the need for second and third tier interventions for intracranial hypertension in severe traumatic brain injury patientsRichárd Soltész, Hargita Dömötör, Ádám L Varga, et al.
Pageof 39

Showing results (281-290 of 389) with videos related to

Sort By:
Pageof 39
Developmental Science|August 23, 2023
Asynchronous development of memory integration and differentiation influences temporal memory organizationChristine Coughlin, Athula Pudhiyidath, Hannah E Roome, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2003
Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptorHippokratis Kiaris, Ioulia Chatzistamou, Andrew V Schally, et al.
Anti-Cancer Drugs|October 11, 2001
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormoneI Chatzistamou, A V Schally, J L Varga, et al.
Acta Medica Hungarica|January 1, 1983
Pentagastrin analogues containing alpha-aminooxy acids. VII. Catabolism in vivo and in vitro of a pentagastrin analogue containing N-terminal aminooxyacetyl residueL Varga, G Holzinger, J Németh, et al.
Scandinavian Journal of Gastroenterology|June 1, 1982
Sensitivity of the parietal cell to pentagastrin in health and duodenal ulcer disease: a reappraisalF Halter, U Bangerter, W H Häcki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2003
Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesinCelia A Kanashiro, Andrew V Schally, Kate Groot, et al.
Clinical and Experimental Immunology|April 23, 2010
Changes in the levels of some acute-phase proteins in human immunodeficiency virus-1 infected patients, following interleukin-2 treatmentV H Barbai, E Ujhelyi, J Szlávik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2008
Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1aFelipe F Casanueva, Jesus P Camiña, Marcos C Carreira, et al.
Journal of Internal Medicine|November 20, 2020
A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiencyZs Pólai, Zs Balla, N Andrási, et al.
Injury|September 20, 2024
Controlled lumbar cerebrospinal fluid drainage effectively decreases the need for second and third tier interventions for intracranial hypertension in severe traumatic brain injury patientsRichárd Soltész, Hargita Dömötör, Ádám L Varga, et al.
Pageof 39